Clinical-Grade Mesenchymal Stromal Cells Produced Under Various Good Manufacturing Practice Processes Differ in Their Immunomodulatory Properties: Standardization of Immune Quality Controls-Reference-Cited by-同舟云学术

Clinical-Grade Mesenchymal Stromal Cells Produced Under Various Good Manufacturing Practice Processes Differ in Their Immunomodulatory Properties: Standardization of Immune Quality Controls

Published:2013-06-15 Issue:12 Volume:22 Page:1789-1801
ISSN:1547-3287
Container-title:Stem Cells and Development
language:en
Short-container-title:Stem Cells and Development

Author:

Menard Cedric¹²,Pacelli Luciano³,Bassi Giulio³,Dulong Joelle¹²,Bifari Francesco³,Bezier Isabelle¹²,Zanoncello Jasmina³,Ricciardi Mario³,Latour Maelle¹,Bourin Philippe⁴,Schrezenmeier Hubert⁵,Sensebé Luc⁴,Tarte Karin¹²,Krampera Mauro³

Affiliation:

1. SITI Laboratory, Etablissement Français du Sang Bretagne, CHU Rennes, France.

2. INSERM U917, Université Rennes 1, Rennes, France.

3. Stem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, Italy.

4. Etablissement Français du Sang Pyrénées Méditerranée, Université Paul Sabatier UMR5273-INSERM U1031, Toulouse, France.

5. Institut für Klinische Transfusionmedizin und Immungenetik, German Red Cross Blood Transfusion Service Baden-Württemberg-Hessen and University of Ulm, Ulm, Germany.

Publisher

Mary Ann Liebert Inc

Subject

Cell Biology,Developmental Biology,Hematology

Link

https://www.liebertpub.com/doi/pdf/10.1089/scd.2012.0594

Reference62 articles.

1. Mesenchymal stem cells in health and disease

2. Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study

3. Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease

4. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

Cited by 158 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An update on stem cell therapy for stroke patients: Where are we now?;Journal of Cerebral Blood Flow & Metabolism;2024-04-19

2. Expression of HLA-DR by mesenchymal stromal cells in the platelet lysate era: an obsolete release criterion for MSCs?;Journal of Translational Medicine;2024-01-09

3. Immunomodulatory performance of GMP-compliant, clinical-grade mesenchymal stromal cells from four different sources;Heliyon;2024-01

4. Scaling up stem cell production: harnessing the potential of microfluidic devices;Biotechnology Advances;2023-12

5. Hematopoietic cell-based and non-hematopoietic cell-based strategies for immune tolerance induction in living-donor renal transplantation: A systematic review;Transplantation Reviews;2023-12